Retail sale of pharmaceutical products
ARVANS HOLDINGSELSKAP AS
Revenue 2024
NOK 0
Operating profit
NOK −29,000
Equity
NOK 14.1m
Incorporated
2017
Share capital
NOK 30,000
Key figures · 2024
Equity ratio
100.0%
Key figures over time · 2024
| Key figures | 2024 | Trend |
|---|---|---|
| Lønnsomhet | ||
| Return on assets (%%) | -0.2% | |
| Likviditet | ||
| Working capital | 287k | |
| Soliditet | ||
| Equity ratio (%%) | 100.0% | |
| Debt-to-equity ratio | 0.00 | |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.